Patents by Inventor Takahiro Kunisada

Takahiro Kunisada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9890360
    Abstract: A method that includes bringing a nuclear reprogramming substance (DLX4 gene, OCT3/4 gene, and SOX2 gene) into contact with a cell and thereby producing iPS cells.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: February 13, 2018
    Assignees: GIFU UNIVERSITY, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Kenichi Tezuka, Naritaka Tamaoki, Kazuki Iida, Tomoko Kawaguchi, Hitomi Aoki, Takahiro Kunisada, Toshiyuki Shibata, Naoki Goshima
  • Publication number: 20160296669
    Abstract: An object of the present invention is to provide a method for efficiently and reproducibly producing a graft material having a high recovery effect on dysfunction caused by nerve damage. The present invention provides a method for producing a graft material for treating nerve damage, including a step of culturing a dental pulp stem cell in a medium substantially containing no growth factors except FGF2, and others.
    Type: Application
    Filed: May 14, 2014
    Publication date: October 13, 2016
    Inventors: Kenichi TEZUKA, Tomoko KAWAGUCHI, Takahiro KUNISADA, Toshiyuki SHIBATA, Hidefumi FUKUMITSU, Shoei FURUKAWA
  • Publication number: 20160208218
    Abstract: A method that includes bringing a nuclear reprogramming substance (DLX4 gene, OCT3/4 gene, and SOX2 gene) into contact with a cell and thereby producing iPS cells.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicants: GIFU UNIVERSITY, NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    Inventors: Kenichi TEZUKA, Naritaka TAMAOKI, Kazuki IIDA, Tomoko KAWAGUCHI, Hitomi AOKI, Takahiro KUNISADA, Toshiyuki SHIBATA, Naoki GOSHIMA
  • Publication number: 20110201110
    Abstract: The present invention provides a method of producing induced pluripotent stem (iPS) cells, comprising bringing a nuclear reprogramming substance into contact with dental pulp stem cells. By using dental pulp stem cells as a source of somatic cells, the efficiency of establishment of human iPS cells by transfer of 3 or 4 factors can be improved dramatically. Additionally, dental pulp stem cells are easily available because they can be isolated and prepared from extracted wisdom teeth and teeth extracted because of periodontal disease and the like, so that they can be used widely as a source of somatic cells for iPS cell banks.
    Type: Application
    Filed: October 2, 2008
    Publication date: August 18, 2011
    Applicants: GIFU UNIVERSITY, KYOTO UNIVERSITY
    Inventors: Kenichi Tezuka, Toshiyuki Shibata, Takahiro Kunisada, Naritaka Tamaoki, Tomoko Takeda, Shinya Yamanaka, Kazutoshi Takahashi
  • Publication number: 20060134078
    Abstract: A medium containing hepatocyte growth factor (HGF) was shown to induce neurosphere formation. Furthermore, the addition of HGF to a culture medium containing FGF-2, EGF, or both increased both the size and number of newly formed neurospheres. Thus, the present invention relates to a growth medium comprising HGF for culturing neural stem cells and methods for culturing the cells using the culture medium.
    Type: Application
    Filed: December 2, 2003
    Publication date: June 22, 2006
    Applicant: AnGes MG, Inc.
    Inventors: Jouji Kokuzawa, Shinichi Yoshimura, Hideomi Kitajima, Jun Shinoda, Yasuhiko Kaku, Toru Iwama, Ryuichi Morishita, Takahiro Kunisada, Noboru Sakai